Register your Account

Sign Up with us and Enjoy!
User name Email First Name Last Name Contact info

A password will be e-mailed to you.

MOST ACTIVE VOLUME STOCKS: Celladon Corp, Dmh International Incorporated, Mondelez International Inc


New York, NY – May 28, 2015
OTC Fire provides it’s members with a free newsletter that reports up to the minute information and exclusive charts on cheap, undervalued, and hidden stocks traded on the NASDAQ, NYSE, AMEX, and OTC Markets with the potential of fast gains.

Make 800% Gains, subscribe for free at http://www.otcfire.com

OTC Fire has issued a news alert on the following MOST ACTIVE VOLUME STOCKS;

Celladon Corp (NASDAQ:CLDN) is currently trading at $2.25 up 4.17%.
Celladon Corporation Celladon is a clinical-stage biotechnology company. The Company is in the business of calcium dysregulation by targeting SERCA enzymes to develop therapies for diseases with tremendous unmet medical needs.

Dmh International Incorporated (OTCBB:DMHI) is currently trading at $0.0011 up 27.907%.
DMH International, Inc. is in the business of developing a suite of medical software products. The Company’s Virtual Physician’s Network is a Health Insurance Portability and Accountability Act HIPAA compliant and private mobile and Web-based app solution. The solution is aimed at surgeons, hospitals, surgery centers, healthcare professionals, medical device/pharmaceutical vendors, and medical associations and societies.

Mondelez International Inc (NASDAQ:MDLZ) is currently trading at $40.215 up 0.187%.
Mondelez International, Inc. Mondelez International is a snack manufacturing company. The Company manufactures and markets food and beverage products for consumers in approximately 165 countries around the world.

Stocks On Fire

OTC Fire is working on its next Stocks On Fire Special Report. These Special Reports typically see fast gains. Reports are issued to members only, Go to http://www.otcfire.com to subscribe for free.

Disclosure
OTC Fire is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. This press release may contain several forward looking statements. Please visit our website for complete risks and disclosures.

Site Preview:

 

Related Press realease: